GSK reports positive pivotal phase III data for next-generation low carbon version of Ventolin metered dose inhaler: London, UK Thursday, October 23, 2025, 11:00 Hrs [IST] GSK plc ...
GSK (GSK) announced positive phase III data from its clinical program to develop a next-generation version of its metered dose inhaler, Ventolin.
GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced positive results from its phase III clinical trials for a ...
Medpage Today on MSN
Triple Therapy Inhaler Improves Lung Function in Poorly Controlled Asthma
CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback